<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Bioeng. Biotechnol.</journal-id>
<journal-title>Frontiers in Bioengineering and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Bioeng. Biotechnol.</abbrev-journal-title>
<issn pub-type="epub">2296-4185</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1254863</article-id>
<article-id pub-id-type="doi">10.3389/fbioe.2023.1254863</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Bioengineering and Biotechnology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Optimizing CRE and PhiC31 mediated recombination in <italic>Aedes aegypti</italic>
</article-title>
<alt-title alt-title-type="left-running-head">Carabajal Paladino et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fbioe.2023.1254863">10.3389/fbioe.2023.1254863</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Carabajal Paladino</surname>
<given-names>Leonela Z.</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/2413691/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wilson</surname>
<given-names>Ray</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tng</surname>
<given-names>Priscilla Y. L.</given-names>
</name>
<uri xlink:href="https://loop.frontiersin.org/people/1811613/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dhokiya</surname>
<given-names>Vishaal</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2372729/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keen</surname>
<given-names>Elizabeth</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cuber</surname>
<given-names>Piotr</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2201076/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Larner</surname>
<given-names>Will</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rooney</surname>
<given-names>Sara</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nicholls</surname>
<given-names>Melanie</given-names>
</name>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Uglow</surname>
<given-names>Anastasia</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Williams</surname>
<given-names>Luke</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anderson</surname>
<given-names>Michelle A. E.</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/503349/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Basu</surname>
<given-names>Sanjay</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leftwich</surname>
<given-names>Philip T.</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1343941/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Alphey</surname>
<given-names>Luke</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/973012/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff>
<institution>Arthropod Genetics Group</institution>, <institution>The Pirbright Institute</institution>, <addr-line>Woking</addr-line>, <country>United Kingdom</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/688765/overview">Sanjay Vashee</ext-link>, J. Craig Venter Institute, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1684666/overview">Yu Cai</ext-link>, Temasek Life Sciences Laboratory, Singapore</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1153852/overview">Feng Wang</ext-link>, Southwest University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Luke Alphey, <email>luke.alphey@york.ac.uk</email>
</corresp>
<fn fn-type="present-address" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>
<bold>Present addresses:</bold> Ray Wilson, The Department of Biology, University of York, York, United Kingdom Michelle A. E. Anderson, The Department of Biology, University of York, York, United Kingdom Luke Alphey, The Department of Biology, University of York, York, United Kingdom</p>
<p>Vishaal Dhokiya, Department of Vector Biology, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom Sara Rooney, Department of Vector Biology, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom</p>
<p>Elizabeth Keen, School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom</p>
<p>Piotr Cuber, Molecular Laboratories, Core Research Laboratories, Natural History Museum, London, United Kingdom</p>
<p>Will Larner, School of Live Sciences, University of Warwick, Coventry, United Kingdom</p>
<p>Anastasia Uglow, Forest Research, Farnham, United Kingdom</p>
<p>Luke Williams, Animal and Plant Health Agency, Addlestone, United Kingdom</p>
<p>Sanjay Basu, Molecular Biology Team, R&#x26;D Division, Oxford, United Kingdom</p>
<p>Philip T. Leftwich, School of Biological Sciences, University of East Anglia, Norwich, United Kingdom</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>09</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1254863</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>07</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>08</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Carabajal Paladino, Wilson, Tng, Dhokiya, Keen, Cuber, Larner, Rooney, Nicholls, Uglow, Williams, Anderson, Basu, Leftwich and Alphey.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Carabajal Paladino, Wilson, Tng, Dhokiya, Keen, Cuber, Larner, Rooney, Nicholls, Uglow, Williams, Anderson, Basu, Leftwich and Alphey</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Introduction:</bold> Genetic manipulation of <italic>Aedes aegypti</italic> is key to developing a deeper understanding of this insects&#x2019; biology, vector-virus interactions and makes future genetic control strategies possible. Despite some advances, this process remains laborious and requires highly skilled researchers and specialist equipment.</p>
<p>
<bold>Methods:</bold> Here we present two improved methods for genetic manipulation in this species. Use of transgenic lines which express Cre recombinase and a plasmid-based method for expressing PhiC31 when injected into early embryos.</p>
<p>
<bold>Results:</bold> Use of transgenic lines which express Cre recombinase allowed, by simple crossing schemes, germline or somatic recombination of transgenes, which could be utilized for numerous genetic manipulations. PhiC31 integrase based methods for site-specific integration of genetic elements was also improved, by developing a plasmid which expresses PhiC31 when injected into early embryos, eliminating the need to use costly and unstable mRNA as is the current standard.</p>
<p>
<bold>Discussion:</bold> Here we have expanded the toolbox for synthetic biology in <italic>Ae. aegypti</italic>. These methods can be easily transferred into other mosquito and even insect species by identifying appropriate promoter sequences. This advances the ability to manipulate these insects for fundamental studies, and for more applied approaches for pest control.</p>
</abstract>
<kwd-group>
<kwd>integration</kwd>
<kwd>plasmid</kwd>
<kwd>cassette exchange</kwd>
<kwd>transgenesis</kwd>
<kwd>mosquito</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Synthetic Biology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>
<italic>Aedes aegypti</italic> is the key mosquito vector of a range of important arboviruses including dengue virus, Zika virus, chikungunya virus and yellow fever virus (<xref ref-type="bibr" rid="B36">World Health Organisation, 2014</xref>). A better understanding of its life cycle, methods of population control, and host-virus interaction, among others, is therefore important. Some studies, e.g., the generation of genetic control methods such as engineered sterile males or gene drives, benefit from the use of genetic manipulation of the mosquito (<xref ref-type="bibr" rid="B3">Alphey, 2014</xref>).</p>
<p>Genetic transformation of <italic>Ae. aegypti</italic>, i.e., stable integration of a foreign sequence (transgene), was first reported by <xref ref-type="bibr" rid="B12">Coates et al. (1998)</xref>, who used the <italic>mariner</italic> transposable element to insert a wild-type copy of the <italic>Drosophila melanogaster cinnabar</italic> gene into an <italic>Ae. aegypti</italic> strain mutant for the homologous gene <italic>kynurenine hydroxylase</italic>. Since then, there has been a plethora of reports of the successful generation of <italic>Ae. aegypti</italic> transgenic lines for basic studies, and also directed towards developing functional strains for disease control. Despite significant improvements, the generation of transgenic mosquitoes is still laborious and a specialist activity available in relatively few labs. For this reason, alternative methods for transformation, and means to maximise the value and utility of each transgenic line, would be highly desirable.</p>
<p>
<italic>In vivo</italic> recombination, primarily using the Cre-<italic>lox</italic> system, has been extremely valuable in animal genetics (<xref ref-type="bibr" rid="B27">Nagy, 2000</xref>). Initial attempts to use this tool in <italic>Ae. aegypti</italic> indicated a rather low efficiency (<xref ref-type="bibr" rid="B19">Jasinskiene et al., 2003</xref>). Perhaps as a result, the system has been subsequently under-utilised, with the exception of some &#x201c;cassette exchange&#x201d; transformation experiments (<xref ref-type="bibr" rid="B28">Nimmo et al., 2006</xref>; <xref ref-type="bibr" rid="B16">Haghighat-Khah et al., 2015</xref>; <xref ref-type="bibr" rid="B15">H&#xe4;cker et al., 2017</xref>).</p>
<p>Cre recombinase is an enzyme expressed by the coliphage P1 that recognises short asymmetrical <italic>lox</italic> sequences and catalyses their recombination (<xref ref-type="bibr" rid="B8">Austin et al., 1981</xref>; <xref ref-type="bibr" rid="B31">Sauer, 1987</xref>). When both <italic>lox</italic> sequences have the same orientation, the recombination event will result in the deletion of the fragment between both <italic>lox</italic> sites, leaving only one <italic>lox</italic> sequence behind (<xref ref-type="fig" rid="F1">Figure 1A</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>
<bold>(A)</bold> Schematic representation of the removal of a DNA fragment (red) leaving one <italic>lox</italic> sequence behind (white arrow). <bold>(B)</bold> Schematic representation of plasmid tPUb-Cre which includes the elements necessary for the ubiquitous expression of Cre recombinase (grey segments) and a transformation marker providing yellow fluorescence in most tissues (yellow segments: yellow body transformation marker, Hr5-<italic>ie1</italic>-ZsYellow). <bold>(C)</bold> Schematic representation of plasmid Shu-Cre which includes the elements necessary for germline expression of Cre recombinase (grey segments) and a blue eye-specific transformation marker (blue segments: 3xP3-ECFP). tPUb: truncated <italic>Polyubiquitin</italic> promoter, Cre: Cre recombinase nucleotide sequence, p10: <italic>Autographa californica</italic> nucleopolyhedrovirus (AcMNPV) <italic>p10</italic> 3&#x2032;UTR, K10: <italic>Drosophila melanogaster fs(1)K10</italic> 3&#x2032;UTR, ZsY: <italic>Zoanthus</italic> sp. yellow fluorescent protein, Hr5-<italic>ie1</italic>: AcMNPV, <italic>ie1</italic> promoter fused with homologous region 5 (hr5) enhancer, Shu_p: s<italic>hut-down</italic> promoter, Shu_3&#x2019;: <italic>shut-down</italic> 3&#x2032;UTR, ECFP: enhanced cyan fluorescent protein, 3xP3: three tandem repeats of Pax-6 homodimer binding site fused to a basal promoter element. Cre-expressing plasmids have additional elements not shown, e.g., <italic>piggyBac</italic> terminal sequences.</p>
</caption>
<graphic xlink:href="fbioe-11-1254863-g001.tif"/>
</fig>
<p>The native <italic>lox</italic>P sequence from phage P1 comprises two inverted repeats separated by a spacer region (<xref ref-type="bibr" rid="B18">Hoess et al., 1982</xref>). The efficiency of the recombination is determined by the homology within the spacer region (<xref ref-type="bibr" rid="B17">Hoess et al., 1986</xref>), while the affinity of the recombinase is determined by the inverted repeat palindromic arms (<xref ref-type="bibr" rid="B2">Albert et al., 1995</xref>). Genome screening and directed mutation of the spacer region have generated several additional <italic>lox</italic> sites that can be used for genome manipulation (<xref ref-type="bibr" rid="B2">Albert et al., 1995</xref>; <xref ref-type="bibr" rid="B7">Araki et al., 1997</xref>; <xref ref-type="bibr" rid="B23">Lee and Saito, 1998</xref>; <xref ref-type="bibr" rid="B22">Langer et al., 2002</xref>; <xref ref-type="bibr" rid="B25">Livet et al., 2007</xref>).</p>
<p>The use of Cre recombinase was previously described in <italic>Ae. aegypti</italic>, based on micro-injection of either purified Cre enzyme, capped mRNA helper, or a plasmid encoding Cre (<xref ref-type="bibr" rid="B19">Jasinskiene et al., 2003</xref>; <xref ref-type="bibr" rid="B28">Nimmo et al., 2006</xref>; <xref ref-type="bibr" rid="B16">Haghighat-Khah et al., 2015</xref>; <xref ref-type="bibr" rid="B15">H&#xe4;cker et al., 2017</xref>). Here we revisited the feasibility of <italic>in vivo</italic> recombination using Cre expressed both in germline to produce offspring with modified genomes, and in somatic cells to produce somatic mosaics. We tested the efficiency of the transgenic mosquito lines expressing Cre, in different constructs that can then be modified for a variety of studies, and we were able to achieve each intended manipulation with good efficiency.</p>
<p>Another useful recombinase, which may be used in combination with Cre-<italic>lox</italic>, is the integrase enzyme expressed by <italic>Streptomyces</italic> temperate phage PhiC31, that catalyses the unidirectional and stable integration of large DNA fragments in specific sites. In synthetic biology applications, the enzyme catalyses the recombination of the phage attachment site (<italic>attP</italic>) typically inserted into the target genome after using conventional transgenesis, and the bacterial attachment site (<italic>attB</italic>) present in the donor plasmid. As a result, new hybrid <italic>attL</italic> and <italic>attR</italic> sites are generated. Unlike <italic>lox</italic> sites, <italic>attP</italic> and <italic>attB</italic> are substantially different in sequence, so the recombinant sequences <italic>attL</italic> and <italic>attR</italic> do not match either and are no longer recognised by the integrase (<xref ref-type="bibr" rid="B32">Thorpe and Smith, 1998</xref>). Consequently, recombination mediated by PhiC31 integrase is essentially irreversible. This has allowed its use for germline transformation, whereas with Cre-<italic>lox</italic> recombination the equilibrium of the reversible reaction is directed heavily towards the non-integrated form. Though mutant derivatives of <italic>lox</italic> can potentially be used to reduce the rate of excision, initial experiments indicated PhiC31 to be much preferable (<xref ref-type="bibr" rid="B28">Nimmo et al., 2006</xref>).</p>
<p>Transformation of <italic>Ae. aegypti</italic> using PhiC31 integrase is traditionally performed by expressing the enzyme from mRNA included in the injection mix (<xref ref-type="bibr" rid="B28">Nimmo et al., 2006</xref>; <xref ref-type="bibr" rid="B13">Franz et al., 2011</xref>; <xref ref-type="bibr" rid="B21">Khoo et al., 2013</xref>; <xref ref-type="bibr" rid="B16">Haghighat-Khah et al., 2015</xref>). The use of mRNA adds extra steps to the transformation procedure, as it needs to be transcribed <italic>in vitro</italic>, DNase treated, purified, precipitated, and resuspended. Efficiency, convenience and reproducibility are also potentially affected by the relative instability of this mRNA. Here we improved this tool by expressing the PhiC31 enzyme from a plasmid included in the injection mix, avoiding the use of mRNA.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Plasmid construction</title>
<p>Plasmids were generated by standard molecular biology techniques including HiFi assembly (New England BioLabs). All plasmids were prepared for microinjection using the NucleoBond Xtra Midiprep kit EF (Machery-Nagel) and confirmed by Sanger sequencing. Sequences of the plasmids designed for this manuscript and of the transgenes of the transgenic lines used are deposited into GenBank, and the accession numbers are detailed in <xref ref-type="sec" rid="s12">Supplementary Table S1</xref>.</p>
</sec>
<sec id="s2-2">
<title>2.2 General mosquito maintenance</title>
<p>
<italic>Aedes aegypti</italic> mosquitoes (Liverpool wild-type strain and transgenics derived from them) were reared at 28&#xb0;C and 70% relative humidity with a 14:10&#xa0;h light:dark cycle. Adults were kept in BugDorm cages with cotton wool pads soaked with 10% sucrose solution. Transgenic lines were maintained in hemizygous state by crossing transgenic males with wild-type females at a 1:2 male:female ratio. From day 5&#x2013;7 post-eclosure, females were blood fed once every 5&#xa0;days, three times, to collect three ovipositions. Defibrinated horse blood (TCS) was offered until most of the females were engorged using a Hemotek membrane feeding system (Hemotek Ltd.) covered with hog gut and an over-layer of parafilm. Two days after blood meal, egg cups consisting of 1 oz clear polypropylene portion pots with a strip of coffee filter paper wrapped inside and half filled with reverse osmosis water, were added to the cages to allow egg laying. The egg cups were removed 5 days later, and egg papers hatched when required. Eggs were vacuum hatched for 2&#xa0;h in 50&#xa0;ml solution of reverse osmosis water with LiquiFry N&#xb0; 1 (Interpet) (500&#xa0;ml of water &#x2b;6 drops of LiquiFry). The larvae were then transferred to a new tray with reverse osmosis water and fed TetraMin ornamental Fish Flakes <italic>ad libitum</italic>. Transgenic mosquitoes were identified in larval or pupal stages based on their fluorescent marker profile using an MZ10F stereomicroscope (Leica Microsystems) equipped with suitable filters. Mosquitoes were sexed under a stereomicroscope at the pupal stage according to the shape of the genital lobe.</p>
<p>All mosquito procedures were reviewed and approved by the Biological Agents and Genetic Modification Safety Committee (BAGMSC) at The Pirbright Institute.</p>
</sec>
<sec id="s2-3">
<title>2.3 Generation of transgenic lines</title>
<p>Cages with approximately 1,000 5&#x2013;7&#xa0;days post-eclosure wild-type females mated with 500 wild-type males were blood fed as described above in the general mosquito maintenance section. In order to collect embryos within 1&#xa0;hour of oviposition for microinjection, no substrate for oviposition was provided. Five to 7&#xa0;days after the blood meal, 15&#x2013;20 females were transferred into a <italic>Drosophila</italic> tube with damp cotton wool covered by a layer of filter paper and kept for 20&#x2013;30&#xa0;min in the dark to promote oviposition. White eggs were lined up side by side in the same orientation on a piece of filter paper and then transferred onto a cover slip with Scotch Double Sided Tape 665 (3M). Eggs were covered with halocarbon oil 27 (Sigma Aldrich) to prevent desiccation before microinjection in their posterior end. Injections were performed using Sutter quartz needles (1.0&#xa0;mm external diameter 0.70&#xa0;mm internal diameter needles with filaments) drawn out on a Sutter P-2000 laser micropipette puller (Sutter Instrument) with the following program: Heat &#x3d; 729, FIL &#x3d; 4, VEL &#x3d; 40, DEL &#x3d; 128, PUL &#x3d; 134, LINE &#x3d; 1. Injections were carried out using a standard microinjection station equipped with a FemtoJet 4x microinjector (Eppendorf). The injection mix contained 500&#xa0;ng/&#x3bc;l of the plasmid intended for insertion, 300&#xa0;ng/&#x3bc;l of helper plasmid AePUb-hyperactive <italic>piggyBac</italic> transposase (<xref ref-type="bibr" rid="B5">Anderson et al., 2022</xref>) for the generation of transgenic lines or AePUb-PhiC31 (this manuscript) for PhiC31 mediated integration, 1x Injection buffer (<xref ref-type="bibr" rid="B12">Coates et al., 1998</xref>) and endotoxin-free water.</p>
<p>After microinjection, the eggs were washed with water and transferred onto damp filter paper in a moist chamber. Five days after injection the eggs were vacuum hatched as described for general maintenance. The collected pupae were sexed under a stereomicroscope. Each Gen<sub>0</sub> male was single crossed with 5 wild-type females, and the individuals were pooled in groups of 3&#x2013;5 single crosses after 48&#xa0;h. Gen<sub>0</sub> females were pooled in groups of 4&#x2013;5 females and 8&#x2013;10 wild-type males. The cages were fed with 10% sucrose, blood fed every 5&#x2013;6&#xa0;days and 5 ovipositions were collected in total. The Gen<sub>1</sub> egg papers were hatched as previously described, and the 3rd-4th instar larvae were screened for the presence of the transformation marker. Single positive Gen<sub>1</sub> individuals were crossed with wild-type counterparts and maintained as described above.</p>
<p>The number of transgene insertions and sex-linkage of the constructs were assessed according to standard rearing procedures by crossing transgenic males to wild-type females and quantifying the number of males and females of wild-type and transgenic phenotypes, and comparing them to the expected frequencies for an autosomal single insertion (i.e. 50% males and 50% females, 50% transgenic and 50% wild-type). Flanking PCR was also used (see protocol in the Molecular analysis section). Only lines with single insertions were used in experiments. Information regarding the insertion site of the lines used in these experiments is detailed in <xref ref-type="sec" rid="s12">Supplementary Table S2</xref>.</p>
</sec>
<sec id="s2-4">
<title>2.4 Experimental crosses</title>
<p>50 females and 25/50 males of the corresponding mosquito lines (wild-type or transgenics) were pooled together according to the experiment (see Results section) and maintained as described above. For screening, 3 replicates of 300 eggs each were hatched and kept in trays with 1.5&#xa0;l of reverse osmosis water and fed with TetraMin ornamental Fish Flakes <italic>ad libitum.</italic> This was done to ensure optimal developmental conditions for all the genotypes. Individuals were screened in larval or pupae stage and photographed when needed using a DFC7000 T camera (Leica Microsystems).</p>
</sec>
<sec id="s2-5">
<title>2.5 Statistical analysis</title>
<p>Chi square tests of independence were used in crosses involving the tPUb-Cre and Shu-Cre lines to study the egg to pupa survival of the double hemizygous, both single hemizygous and wild-type individuals of the different crosses. The observed values were calculated as an average of those observed in the three replicates. For individuals carrying a construct susceptible to recombination, the values of the non-recombined and recombined phenotypes were added. The expected values were calculated considering a normal segregation of the constructs and full survival of the phenotype, i.e., 25% of the average of the total number of individuals recovered per replicate.</p>
<p>Student&#x2019;s <italic>t</italic>-tests were carried out to compare number of individuals per genotype between crosses of the Shu-Cre line.</p>
<p>All tests were carried out using R (ver 4.2.2) (<xref ref-type="bibr" rid="B30">R Core Team, 2022</xref>) in RStudio 2022.12.0 &#x2b; 353, with the MASS (<xref ref-type="bibr" rid="B33">Venables and Ripley, 2002</xref>), rstatix (<xref ref-type="bibr" rid="B20">Kassambara, 2023</xref>) and dplyr (<xref ref-type="bibr" rid="B35">Wickham et al., 2023</xref>)</p>
</sec>
<sec id="s2-6">
<title>2.6 Molecular analysis</title>
<p>Genomic DNA was extracted from larvae or pupae of the selected lines using NucleoSpin Tissue gDNA extraction kit (Macherey-Nagel).</p>
<p>Flanking PCR was performed according to previously reported methods (<xref ref-type="bibr" rid="B24">Liu and Chen, 2007</xref>; <xref ref-type="bibr" rid="B26">Martins et al., 2012</xref>). Genomic DNA was digested using enzymes DpnII, MspI and NcoI (New England Biolabs) and PCRs were performed with DreamTaq (Thermo Fisher Scientific). Adaptors were built with primers 6,770 (5&#x2032;-GTG&#x200b;TAG&#x200b;CGT&#x200b;GAA&#x200b;GAC&#x200b;GAC&#x200b;AGA&#x200b;AAG&#x200b;GGC&#x200b;GTG&#x200b;GTG&#x200b;CGG&#x200b;AGG&#x200b;GCGGT&#x200b;G-3&#x2032;) and 6,776 (5&#x2032;-GAT&#x200b;CCA&#x200b;CCG&#x200b;CCC&#x200b;TCC&#x200b;G-3&#x2032;) for DpnII, 6,770 and 6,775 (5&#x2032;-CGC&#x200b;ACC&#x200b;GCC&#x200b;CTC&#x200b;CG-3&#x2032;) for MspI, and 6,770 and 6,789 (5&#x2032;-CAT&#x200b;GCA&#x200b;CCG&#x200b;CCC&#x200b;TCC&#x200b;G-3&#x2032;) for NcoI. The primary PCR used primers 6,774 (5&#x2032;- GTG&#x200b;TAG&#x200b;CGT&#x200b;GAA&#x200b;GAC&#x200b;GAC&#x200b;AGA&#x200b;A-3&#x2032;) and 6,772 (5&#x2032;-CAG&#x200b;TGA&#x200b;CAC&#x200b;TTA&#x200b;CCG&#x200b;CAT&#x200b;TGA&#x200b;CAA&#x200b;G-3&#x2032;) to amplify the 5&#x2032; insertion site, and 6,774 and 6,773 (5&#x2032;- CAG&#x200b;ACC&#x200b;GAT&#x200b;AAA&#x200b;ACA&#x200b;CAT&#x200b;GCG&#x200b;TCA-3&#x2032;) to amplify the 3&#x2032; insertion site. The nested PCR used primers 6,774 and 6,771 (5&#x2032;-GGC&#x200b;GAC&#x200b;TGA&#x200b;GAT&#x200b;GTC&#x200b;CTA&#x200b;AAT&#x200b;GCA&#x200b;C-3&#x2032;) to amplify the 5&#x2032; insertion site, and 6,774 and 6,787 (5&#x2032;-ACG&#x200b;CAT&#x200b;GAT&#x200b;TAT&#x200b;CTT&#x200b;TAA&#x200b;CGT&#x200b;ACG-3&#x2032;) to amplify the 3&#x2032;insertion site.</p>
<p>PCR reactions for the other experiments were performed in a final volume of 100&#xa0;&#x3bc;l using 50&#x2013;150&#xa0;ng of template, 5&#xa0;&#x3bc;l of primer forward 10&#xa0;&#x3bc;M, 5&#xa0;&#x3bc;l of primer reverse 10&#xa0;&#x3bc;M, 50&#xa0;&#x3bc;l of Q5 High-Fidelity 2x Master Mix (New England Biolabs) and water.</p>
<p>To test for the removal of internal sequences for interaction analyses, primers 6,676 (5&#x2032;-TGT&#x200b;GCA&#x200b;GTC&#x200b;GGT&#x200b;TAG&#x200b;TTG&#x200b;GGA&#x200b;AAG&#x200b;G-3&#x2032;) and 5,038 (5&#x2032;-GGC&#x200b;CAT&#x200b;TGT&#x200b;GAC&#x200b;TTT&#x200b;GAA&#x200b;GGT&#x200b;GGA&#x200b;GG-3&#x2032;) were used. Cycling conditions included an initial denaturation step at 98&#xb0; for 30&#xa0;s, 35 cycles of 98&#xb0; 10&#xa0;s, 72&#xb0; 1&#xa0;min 35&#xa0;s, and a final elongation at 72&#xb0; for 2&#xa0;min. A fragment of 3,135&#xa0;bp was expected if the internal sequence was present, and of 350&#xa0;bp if the sequence was absent.</p>
<p>To test for the removal of backbone sequences, primers 5,842 (5&#x2032;-CAG&#x200b;ACA&#x200b;TGA&#x200b;TAA&#x200b;GAT&#x200b;ACA&#x200b;TTG&#x200b;ATG-3&#x2032;) and 6,792 (5&#x2032;-AAT&#x200b;GAC&#x200b;ATC&#x200b;ATC&#x200b;CAC&#x200b;TGA&#x200b;TCG-3&#x2032;) were used. Cycling conditions included an initial denaturation step at 98&#xb0; for 30&#xa0;s, 35 cycles of 98&#xb0; 10&#xa0;s, 59&#xb0; 15&#xa0;s and 72&#xb0; 2&#xa0;min 45&#xa0;s, and a final elongation at 72&#xb0; for 2&#xa0;min. A fragment of 5,281&#xa0;bp was expected if the backbone sequence was present, and of 578&#xa0;bp if the sequence was absent.</p>
<p>To test for correct PhiC31 integrase mediated integration, primer pair 6,707 (5&#x2032;-TCG&#x200b;GTC&#x200b;TGT&#x200b;ATA&#x200b;TCG&#x200b;AGG&#x200b;TTT&#x200b;AT-3&#x2032;) and 6,799 (5&#x2032;-CCC&#x200b;TTC&#x200b;ACG&#x200b;GTG&#x200b;AAG&#x200b;TAG&#x200b;TG-3&#x2032;) was used to amplify the <italic>attL</italic> region, and primer pair 6,795 (5&#x2032;-GCA&#x200b;CAA&#x200b;GCT&#x200b;GGA&#x200b;GTA&#x200b;CAA&#x200b;CTA-3&#x2032;) and 6,791 (5&#x2032;-CCA&#x200b;GTT&#x200b;CGG&#x200b;TTA&#x200b;TGA&#x200b;GCC&#x200b;GT-3&#x2032;) was used to amplify the <italic>attR</italic> region. Cycling conditions included an initial denaturation step at 98&#xb0; for 30&#xa0;s, 35 cycles of 98&#xb0; 10&#xa0;s, 63&#xb0; 15&#xa0;s and 72&#xb0; 45&#xa0;s, and a final elongation at 72&#xb0; for 2&#xa0;min. Fragments of 1,101&#xa0;bp and 1,393&#xa0;bp were expected for <italic>attL</italic> and <italic>attR</italic>, respectively.</p>
<p>PCR products were run in a 1% agarose gel with SYBR&#x2122; Safe DNA Gel Stain (Thermo Fisher Scientific) and photographed using a Bio-Rad Gel Doc imaging system. As clear single bands were observed in all cases, the remaining PCR product was purified using NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel) and Sanger sequenced using both forward and reverse primers.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Cre recombinase expressing lines</title>
<p>We generated transgenic mosquito lines expressing Cre recombinase either in a broad range of tissues using a truncation of the <italic>Polyubiquitin</italic> gene promoter (AAEL003888, <xref ref-type="bibr" rid="B9">Bartholomeeusen et al., 2018</xref>) (tPUb-Cre, <xref ref-type="fig" rid="F1">Figure 1B</xref>) or the germline specific <italic>shut-down</italic> gene promoter (from OP823146, <xref ref-type="bibr" rid="B4">Anderson et al., 2023</xref>) (Shu-Cre, <xref ref-type="fig" rid="F1">Figure 1C</xref>). The Cre coding sequence used was modified for expression in <italic>Ae. aegypti</italic> by adjusting codon usage to avoid rare codons (&#x201c;codon-optimised&#x201d;). We tested these lines by crossing them to different transgenic reporter lines.</p>
</sec>
<sec id="s3-2">
<title>3.2 Somatic effect of Cre recombinase expression</title>
<p>To analyse these lines for their somatic effect, we generated a reporter mosquito line carrying the construct PUb-loxP-mCh-stop-loxP-AmC (<xref ref-type="fig" rid="F2">Figure 2A</xref>). These individuals express the red fluorophore mCherry over the whole body; after Cre mediated recombination, the mCherry open reading frame should be removed and the cyan fluorophore AmCyan expressed instead (<xref ref-type="fig" rid="F2">Figure 2A</xref>, <xref ref-type="sec" rid="s12">Supplementary Figure S1</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>
<bold>(A)</bold> Schematic representation of plasmid PUb-loxP-mCh-stop-loxP-AmC before and after Cre mediated recombination. <bold>(B&#x2013;E)</bold> Individuals hemizygous for tPUb-Cre <bold>(I)</bold> or PUb-loxP-mCh-stop-loxP-AmC (ii) and double hemizygous (iii). <bold>(F&#x2013;H)</bold> Individuals hemizygous for PUb-loxP-mCh-stop-loxP-AmC (i) or Shu-Cre (iii), double hemizygous (ii) and wild-type (iv). <bold>(B)</bold> and <bold>(F)</bold>: bright field, <bold>(C)</bold>: ZsYellow filter, <bold>(D)</bold> and <bold>(G)</bold>: mCherry filter, <bold>(E)</bold> and <bold>(H)</bold>: AmCyan filter. Scale bar &#x3d; 1&#xa0;mm. 3xP3: three tandem repeats of Pax-6 homodimer binding site fused to a basal promoter element, mCh: mCherry red fluorescent protein, K10: <italic>Drosophila melanogaster K10</italic> 3&#x2032;UTR, PUb: <italic>Polyubiquitin</italic> promoter, SV40: Simian virus 40 PolyA sequence, AmC: <italic>Anemonia majano</italic> cyan fluorescent protein, p10: <italic>Autographa californica</italic> nucleopolyhedrovirus <italic>p10</italic> 3&#x2032;UTR.</p>
</caption>
<graphic xlink:href="fbioe-11-1254863-g002.tif"/>
</fig>
<p>We screened the F<sub>1</sub> progeny of crosses between hemizygous tPUb-Cre or Shu-Cre individuals with hemizygous counterparts from the reporter line. The three transgenic lines have their own transformation marker making it possible to identify all the genotypes of the F<sub>1</sub>: yellow body for tPUb-Cre, blue optic nerves for Shu-Cre, and red optic nerves for the reporter (<xref ref-type="fig" rid="F1">Figures 1A, B</xref>, <xref ref-type="fig" rid="F2">2A</xref>).</p>
<p>For both types of crosses, all double hemizygous F<sub>1</sub> individuals expressed mCherry and AmCyan over the whole body (<xref ref-type="fig" rid="F2">Figures 2B&#x2013;H</xref>), indicating that the removal of the loxP-mCh-stop-loxP section (leaving one <italic>lox</italic>P sequence behind) occurred in many cells. Whole body expression of Cre in the tPUb-Cre line was expected due to the nature of the promoter. In the Shu-Cre line, although expression of <italic>shut-down</italic> is germline-specific, the promoter fragment used was known to provide some somatic expression as well (<xref ref-type="bibr" rid="B4">Anderson et al., 2023</xref>), which was now visually corroborated.</p>
</sec>
<sec id="s3-3">
<title>3.3 Germline effect of Cre recombinase expression</title>
<p>To analyse the lines for their germline effect we generated a reporter mosquito line carrying the construct loxN-R-loxP-loxN-Y-loxP (<xref ref-type="fig" rid="F3">Figure 3</xref>, <xref ref-type="sec" rid="s12">Supplementary Figure S2</xref>). These mosquitoes express a red body marker from fragment R, and a yellow optic nerves marker from fragment Y. As lines tPUb-Cre and Shu-Cre have yellow body and blue optic nerves markers respectively, all the genotypes deriving from the crosses could be identified (see example in <xref ref-type="sec" rid="s12">Supplementary Figure S3</xref>). The reporter line includes other sequences that are not relevant for this study (<xref ref-type="sec" rid="s12">Supplementary Figure S2</xref>), and hence their effect is not addressed. The use of two overlapping pairs of incompatible <italic>lox</italic> sites&#x2014;<italic>lox</italic>P and <italic>lox</italic>N&#x2014;means that recombination between one pair removes one of the other pair, thus preventing recombination based on that site. Recombination therefore has two possible stable outcomes i) recombination between <italic>lox</italic>P sites deleting segment Y, retaining segment R and therefore red fluorescence; ii) recombination between <italic>lox</italic>N sites deleting segment R, retaining segment Y and therefore yellow fluorescence.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Schematic representation of construct loxN-R-loxP-loxN-Y-loxP. Hr5-<italic>ie1</italic>: AcMNPV, <italic>ie1</italic> promoter fused with homologous region 5 (hr5) enhancer, DsR: <italic>Discosoma</italic> sp. red fluorescent protein, K10: <italic>Drosophila melanogaster K10</italic> 3&#x2032;UTR, SV40: Simian virus 40 PolyA sequence, ZsY: <italic>Zoanthus</italic> sp. yellow fluorescent protein, 3xP3: three tandem repeats of Pax-6 homodimer binding site fused to a basal promoter element.</p>
</caption>
<graphic xlink:href="fbioe-11-1254863-g003.tif"/>
</fig>
<p>We first screened the F<sub>1</sub> progeny of crosses between tPUb-Cre or Shu-Cre with the reporter line. In order to address any possible sex specific effect, both reciprocal crosses were performed for line tPUb-Cre, but as line Shu-Cre is linked to the <italic>m</italic> allele of the <italic>M</italic>/<italic>m</italic> male determining locus (&#x201c;<italic>m</italic>-linked&#x201d;), only Shu-Cre females were used. Double hemizygous F<sub>1</sub> males and females were subsequently crossed to wild-type counterparts, the F<sub>2</sub> was screened, and their phenotypes were assessed for recombination events.</p>
<p>The results for line tPUb-Cre are summarised in <xref ref-type="fig" rid="F4">Figure 4A</xref> and detailed in <xref ref-type="sec" rid="s12">Supplementary Tables S3&#x2013;S6</xref>. The results for line Shu-Cre are summarised in <xref ref-type="fig" rid="F4">Figure 4B</xref> and detailed in <xref ref-type="sec" rid="s12">Supplementary Tables S7, S8</xref>. The analysis of the segregation of the tPUb-Cre and loxN-R-loxP-loxN-Y-loxP constructs (adding up recombined and non-recombined versions of the latter), showed no statistically significant differences with the expected frequencies (25% each&#x2014;double hemizygous, single hemizygous for each insertion and wild-type) (Chi-square test of independence: <italic>p</italic> &#x3e; 0.05). This suggests no substantial lethal effect of the recombinase line or the recombined fragments (power analysis: N &#x3e; 250, &#x3b2; &#x3e; 0.9, &#x3c9; &#x3c; 0.3 for all crosses). Crosses with the tPUb-Cre line produced only one recombinant individual for one of the two possible phenotypes (red body from red body or yellow optic nerves). This indicated little or no expression&#x2014;or function, but see below&#x2014;of Cre in the germline of this strain, likely due to the PUb promoter fragment used in this line.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>
<bold>(A)</bold> Phenotypes of F<sub>2</sub> individuals from crosses between double hemizygous loxN-R-loxP-loxN-Y-loxP and tPUb-Cre with wild-type counterparts. <bold>(B)</bold> Phenotypes of F<sub>2</sub> individuals from crosses between double hemizygous loxN-R-loxP-loxN-Y-loxP and Shu-Cre with wild-type counterparts. Bars represent the average obtained from the three trays analysed, and the error bars are the standard error. Recombined phenotypes are underlined. R &#x2b; Y: loxN-R-loxP-loxN-Y-loxP, R: fragment without segment Y &#x3d; loxN-R-loxP, Cre: tPUb-Cre in A and Shu-Cre in B, Y: fragment without segment R &#x3d; loxN-Y-loxP, WT: wild-type.</p>
</caption>
<graphic xlink:href="fbioe-11-1254863-g004.tif"/>
</fig>
<p>Crosses with the Shu-Cre line generated individuals of each of the two possible recombined phenotypes. Analysis of the observed frequencies of the segregating constructs found no evidence for lethal effect for any of the genotypes (Chi-square test of independence: <italic>p</italic> &#x3e; 0.05), and expression of Cre recombinase in the germline. A linear model was constructed to compare the number of individuals per phenotype between crosses, and no differences were observed (Student&#x2019;s <italic>t</italic>-test: <italic>p</italic> &#x3e; 0.05, <xref ref-type="sec" rid="s12">Supplementary Table S9</xref>). A power analysis indicates that there is no evidence for a difference in efficiency of the Cre recombinase between the male and female germline (&#x3b2; &#x3d; 0.9, <italic>f</italic> &#x3d; 0.2).</p>
<p>The efficiency of the Cre lines in the germline, calculated as the percentage of individuals carrying a recombined construct (R &#x2b; Cre, Y &#x2b; Cre, R and Y) was 0.16% for line tPUb-Cre and between 15.4% and 17.8% for the Shu-Cre line.</p>
</sec>
<sec id="s3-4">
<title>3.4 Further experiments using Shu-Cre</title>
<p>As the Shu-Cre line was found to be highly efficient at inducing recombination in the germline (15.4%&#x2013;17.8% efficiency), we further analysed it using other lines containing <italic>lox</italic> sites.</p>
<sec id="s3-4-1">
<title>3.4.1 Removal of internal sequences for interaction analyses</title>
<p>We used the Shu-Cre line to remove an internal fragment within a transgene of mosquito lines available in the laboratory. These lines were developed to help compare bipartite expression using the tet-off system (<xref ref-type="bibr" rid="B14">Gossen and Bujard, 1992</xref>) (promoter-tTA&#x3e;TRE-reporter) with direct expression (promoter-reporter). Here we focus on the Cre-<italic>lox</italic>N data only.</p>
<p>We used two lines carrying the reporter construct A-loxN-B-loxN-C (<xref ref-type="fig" rid="F5">Figure 5</xref>) in two different locations on chromosome 2: lines D and E (<xref ref-type="sec" rid="s12">Supplementary Table S2</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Schematic representation of construct A-loxN-B-loxN-C. The pink arrows indicate the location of the primers used for validation of the removal of fragment B. 3xP3: three tandem repeats of Pax-6 homodimer binding site fused to a basal promoter element, DsR: <italic>Discosoma</italic> sp. red fluorescent protein, K10: <italic>Drosophila melanogaster K10</italic> 3&#x2032;UTR, AeCPA_p: <italic>Aedes aegypti Carboxypeptidase A</italic> promoter, tTA: tetracycline-controlled transactivator, SV40: Simian virus 40 PolyA sequence, ZsY: <italic>Zoanthus</italic> sp. yellow fluorescent protein, TRE: tetracycline response element, AmC: <italic>Anemonia majano</italic> cyan fluorescent protein, p10: <italic>Autographa californica</italic> nucleopolyhedrovirus <italic>p10</italic> 3&#x2032;UTR.</p>
</caption>
<graphic xlink:href="fbioe-11-1254863-g005.tif"/>
</fig>
<p>The construct A-loxN-B-loxN-C has two transformation markers: red optic nerves for segment A, and yellow optic nerves for segment B (<xref ref-type="fig" rid="F5">Figure 5</xref>). The removal of fragment loxN-B-loxN (leaving a <italic>lox</italic>N behind) should result in the loss of the yellow marker (<xref ref-type="fig" rid="F5">Figure 5</xref>).</p>
<p>Males of each line carrying the construct A-loxN-B-loxN-C were crossed to Shu-Cre females, and the double hemizygous F<sub>1</sub> were crossed to wild-type counterparts. The F<sub>2</sub> was screened (see schematic representation of the expected phenotypes in <xref ref-type="sec" rid="s12">Supplementary Figure S4</xref>); results are summarised in <xref ref-type="fig" rid="F6">Figure 6A</xref> and detailed in <xref ref-type="sec" rid="s12">Supplementary Tables S10, 11</xref>. Analysis of the segregation of the constructs Shu-Cre and A-loxN-B-loxN-C (adding up non-recombined A-loxN-B-loxN-C and recombined A-loxN-C individuals) showed no significant statistical differences (<italic>p</italic> &#x3e; 0.05) with the expected values (25% each&#x2014;double hemizygous, single hemizygous for each insertion and wild-type). It is unclear, however, why fewer A-loxN-B-loxN-C individuals were observed compared to double hemizygous Shu-CreA-loxN-B-loxN-C, as no effect on survival is expected of the Shu-Cre construct (as observed when the germline effect of the line was tested above).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>
<bold>(A)</bold> Genotypes of F<sub>2</sub> individuals from crosses between double hemizygous A-loxN-B-loxN-C and Shu-Cre with wild-type counterparts. Bars represent the average obtained from the three sets of progeny analysed, and the error bars are the standard error. Recombined phenotypes are underlined. <bold>(B)</bold> PCR validation of the removal of fragment B. The pool of recombinant individuals from lines D and E show an amplicon of between 300 and 400&#xa0;bp, expected after the removal of fragment B. The positive control (C&#x2b;) using purified transformation plasmid as template generated an amplicon of between 3,000 and 4000&#xa0;bp, expected if fragment B is present. ABC &#x2b; Cre: double hemizygous carrying A-loxN-B-loxN-C and Shu-Cre, AC &#x2b; Cre: double hemizygous carrying the recombined fragment A-loxN-C (B fragment removed) and Shu-Cre, ABC: individuals carrying the A-loxN-B-loxN-C construct, Cre: individuals carrying Shu-Cre, AC: individuals carrying the recombined version A-loxN-C, WT: wild-type, Rec: recombined, C-: negative control (water).</p>
</caption>
<graphic xlink:href="fbioe-11-1254863-g006.tif"/>
</fig>
<p>The efficiency of the Cre line in the germline, calculated as the percentage of individuals carrying a recombined construct (Shu-CreA-loxN-C and A-loxN-C), was higher in this experiment with 32.49% for Line D and 37.93% for Line E (compared to 15.4%&#x2013;17.8% obtained with the loxN-R-loxP-loxN-Y-loxP lines&#x2014;see previous section).</p>
<p>For a subset of the recombinants, the removal of fragment B was additionally assessed by PCR (<xref ref-type="fig" rid="F6">Figure 6B</xref>). The PCR primers were located within sections A and C (<xref ref-type="fig" rid="F5">Figure 5</xref>, pink arrows). Presence of fragment B should be detected by the amplification of an amplicon of 3,135&#xa0;bp, and the absence of the fragment should generate an amplicon of 350&#xa0;bp. As observed in <xref ref-type="fig" rid="F6">Figure 6B</xref>, recombined lines D and E showed an amplicon of the expected size, the negative control of water (C-) did not produce an amplicon, and the positive control using purified plasmid (C&#x2b;) presented only the larger amplicon. The obtained fragments were purified and the identity of the sequences was confirmed <italic>via</italic> Sanger sequencing (<xref ref-type="sec" rid="s12">Supplementary Table 12</xref>).</p>
</sec>
<sec id="s3-4-2">
<title>3.4.2 Removal of backbone sequences</title>
<p>Methods that integrate an entire plasmid, e.g., PhiC31 mediated integration, insert in the target site sequences that may be undesirable for some downstream studies or uses, e.g., plasmid origin of replication and antibiotic resistance genes. With efficient Cre-<italic>lox</italic> recombination available as shown above, an option to remove undesirable sequences post-integration could be provided by flanking such sequences with suitable <italic>lox</italic> sites. We used the lines generated below using PhiC31 integrase (attL-TRE-AmC-Bb-attR-AeCPA-tTA, <xref ref-type="fig" rid="F7">Figure 7D</xref>) and crossed males of each line to Shu-Cre females. We only used one pool per line since, as expected and validated (see PhiC31 experiment below), all the pools from the same line have the same insertion (<xref ref-type="sec" rid="s12">Supplementary Table 13</xref>). We then selected F<sub>1</sub> males with red body (marker of the target line) and blue eyes (marker of the inserted plasmid in the target line and the Shu-Cre line) (see <xref ref-type="fig" rid="F7">Figure 7D</xref> for the schematic representation of the transgene in the target line; <xref ref-type="fig" rid="F1">Figure 1C</xref> for the representation of the Shu-Cre transgene). As both the target line and the Shu-Cre line share the blue eyes marker, hemizygous males from the target line were not readily distinguished from double hemizygous males. We used at least 50 males per line, crossed them to wild-type females, and screened their offspring.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>
<bold>(A)</bold> Schematic representation of plasmid PUb-PhiC31. <bold>(B)</bold> Schematic representation of the target site. <bold>(C)</bold> Schematic representation of the donor plasmid. <bold>(D)</bold> Schematic representation of the donor plasmid inserted in the target site, and location of primers for PCR testing of <italic>attL</italic> and <italic>attR</italic> junctions and backbone removal (green, yellow and pink arrows, respectively). <bold>(E)</bold> Schematic representation of the insertion after removal of the backbone. <bold>(F)</bold> PCR amplification of junctions including sites <italic>attL</italic> and <italic>attR</italic> in all the pools with positive G<sub>1</sub> (<xref ref-type="table" rid="T1">Table 1</xref>). All lines produced an amplicon of approx. 1,000&#xa0;bp for <italic>attL</italic>, and between 1,200 and 1,500&#xa0;bp for <italic>attR</italic>, as expected. Bb: backbone, PUb: <italic>Polyubiquitin</italic> promoter, PhiC31: <italic>Streptomyces</italic> temperate phage PhiC31 integrase, SV40: Simian virus 40 PolyA sequence, 3&#x2019;pb: 3&#x2019; piggyBac end, attP: phage attachment site, Hr5-<italic>ie1</italic>: <italic>Autographa californica</italic> nucleopolyhedrovirus <italic>ie1</italic> promoter fused with homologous region 5 (hr5) enhancer, <italic>Discosoma</italic> sp. red fluorescent protein, K10: <italic>Drosophila melanogaster K10</italic> 3&#x2019;UTR, tTA: tetracycline-controlled transactivator, AeCPA_p: <italic>Aedes aegypti Carboxypeptidase A</italic> promoter, 5&#x2019;pB: 5&#x2019; piggyBac end, 3xP3: three tandem repeats of Pax-6 homodimer binding site fused to a basal promoter element, ECFP: enhanced cyan fluorescent protein, attB: bacterial attachment site, TRE: tetracycline response element, AmC: <italic>Anemonia majano</italic> cyan fluorescent protein, attL: <italic>attP</italic>&#x2b;<italic>attB</italic> hybrid site, attR: <italic>attB</italic>&#x2b;<italic>attP</italic> hybrid site.</p>
</caption>
<graphic xlink:href="fbioe-11-1254863-g007.tif"/>
</fig>
<p>Due to the design of the donor plasmid used (<xref ref-type="fig" rid="F7">Figure 7C</xref>), the removal of the backbone after the insertion (<xref ref-type="fig" rid="F7">Figure 7D</xref>) also results in the removal of the marker for the transgene (i.e., blue optic nerves, <xref ref-type="fig" rid="F7">Figure 7E</xref>). An effective recombination will produce individuals carrying only the marker of the original <italic>attP</italic> target line (i.e., red body, see <xref ref-type="fig" rid="F7">Figure 7B</xref>).</p>
<p>As it was not possible to accurately identify the phenotype of the parental male (i.e., to easily distinguish hemizygous from double hemizygous due to the shared blue optic nerves marker), no quantitative analysis was performed. For each line tested, progeny with markers indicating recombination (red body but not blue optic nerves) were readily recovered. One such individual was selected from each line and used for subsequent analysis by PCR and Sanger sequencing. The PCR primers were located within the SV40 segment before the backbone and the Hr5-<italic>ie1</italic> promoter of the marker after the backbone (<xref ref-type="fig" rid="F7">Figures 7D,E</xref>, primers 5,842 and 6,792 - pink arrows). Presence of the backbone should be detected by the amplification of an amplicon of 5,281&#xa0;bp, and the absence of this region should generate an amplicon of 578&#xa0;bp (see difference between <xref ref-type="fig" rid="F7">Figures 7D,E</xref>). As observed in <xref ref-type="fig" rid="F8">Figure 8</xref>, lines A, D and C generated an amplicon between 5,000 and 6,000&#xa0;bp before the removal of the backbone (&#x2b;Bb), and a band between 500 and 600&#xa0;bp after recombination (-Bb), the negative control of water (C-) did not produce an amplicon. Sanger sequencing of the obtained amplicons demonstrated precise <italic>lox</italic>P-mediated recombination, and efficient removal of the backbone.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>PCR amplification of the backbone (Bb) before and after crosses to Shu-Cre. Lines A, D and C were tested before (&#x2b;Bb) and after (-Bb) the removal of the backbone of the inserted transgene, producing a large band between 5,000 and 6,000&#x00a0;bp when the backbone was present, and a small band between 500 and 600&#x00a0;bp once the backbone was removed. C-: negative control (water).</p>
</caption>
<graphic xlink:href="fbioe-11-1254863-g008.tif"/>
</fig>
</sec>
<sec id="s3-4-3">
<title>3.4.3 PhiC31 integrase mediated integration</title>
<p>Here we expressed the PhiC31 integrase (Genbank KT894025) in the injection mix from a plasmid using the <italic>Ae. aegypti Polyubiquitin</italic> promoter (<xref ref-type="bibr" rid="B6">Anderson et al., 2010</xref>) (<xref ref-type="fig" rid="F7">Figure 7A</xref>). As target lines we used three mosquito lines available in the laboratory carrying a red body transformation marker (<xref ref-type="fig" rid="F7">Figure 7A</xref>). In line A the transgene is in chromosome 1, in line D it is located in chromosome 2, and in line C it is located in chromosome 3 (<xref ref-type="sec" rid="s12">Supplementary Figure S2</xref>). As donor plasmid we designed the construct attB-TRE-AmC which contains a blue optic nerve marker (<xref ref-type="fig" rid="F7">Figure 7C</xref>). An efficient integration of the donor plasmid will result in individuals carrying two markers, red body and blue optic nerves.</p>
<p>The target lines carry the transgene attP-AeCPA-tTA (<xref ref-type="fig" rid="F7">Figure 7B</xref>), which uses a 1.6&#xa0;kb fragment the <italic>Ae. aegypti Carboxypeptidase A</italic> promoter (AeCPA) to express tTA (<xref ref-type="bibr" rid="B14">Gossen and Bujard, 1992</xref>). The interaction, if any, between the AeCPA-tTA and TRE-AmC elements (represented as grey segments in <xref ref-type="fig" rid="F7">Figures 7B&#x2013;E</xref>) is not relevant for this study and is not discussed.</p>
<p>We injected between 318 and 334 eggs and made between three and five G<sub>0</sub> pools per target line (<xref ref-type="table" rid="T1">Table 1</xref>). For line A we recovered positive G<sub>1</sub> (i.e., individuals bearing both transformation markers) in two out of five pools, for line D we recovered positive G<sub>1</sub> in all four pools, and in line C we recovered positive G1 in two out of three pools. We established the lines by crossing the positive G<sub>1</sub> from each pool separately with wild-type counterparts, and then collected G<sub>2</sub> samples for analysis of the insertion site.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Injections of attB-TRE-AmCyan into three lines (A, D and C) carrying attP-AeCPA-tTA. The survival rate was calculated as: (adult G<sub>0</sub> males &#x2b; adult G<sub>0</sub> females)/injected eggs, and the minimum transformation efficiency as: positive G<sub>1</sub> pools/(adult G<sub>0</sub> males &#x2b; adult G<sub>0</sub> females). Chr.: chromosome.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Target line</th>
<th align="left">Eggs</th>
<th align="left">G<sub>0</sub> larvae</th>
<th align="left">Adult G<sub>0</sub> males</th>
<th align="left">Adult G<sub>0</sub> females</th>
<th align="left">Survival (%)</th>
<th align="left">Pools (positive G<sub>1</sub>) &#x3d; sex of G<sub>0</sub>
</th>
<th align="left">Minimum transformation efficiency (%)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">A (Chr. 1)</td>
<td align="left">318</td>
<td align="left">25</td>
<td align="left">11</td>
<td align="left">9</td>
<td align="left">6.29</td>
<td align="left">A (0),B (0) &#x3d; fem C (1),D (9),E (0) &#x3d; male</td>
<td align="left">10</td>
</tr>
<tr>
<td align="left">D (Chr. 2)</td>
<td align="left">334</td>
<td align="left">21</td>
<td align="left">10</td>
<td align="left">8</td>
<td align="left">5.39</td>
<td align="left">A (28),B (14) &#x3d; fem C (5),D (1) &#x3d; male</td>
<td align="left">22</td>
</tr>
<tr>
<td align="left">C (Chr. 3)</td>
<td align="left">329</td>
<td align="left">11</td>
<td align="left">3</td>
<td align="left">8</td>
<td align="left">3.34</td>
<td align="left">A (2),B (0) &#x3d; fem C (86) &#x3d; male</td>
<td align="left">18</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>After genomic DNA extraction from the different G<sub>2</sub> lines, we corroborated the insertion of the transgene in the target site by amplifying and sequencing both junctions (<xref ref-type="fig" rid="F7">Figure 7D</xref>, <xref ref-type="sec" rid="s12">Supplementary Table S13</xref>). We used primers 6,707 and 6,799 (<xref ref-type="fig" rid="F7">Figure 7D</xref>, green arrows) to amplify <italic>attL</italic>, expecting a product of 1,101&#xa0;bp, and primers 6,795 and 6,791 (<xref ref-type="fig" rid="F7">Figure 7D</xref>, yellow arrows) to amplify <italic>attR</italic>, expecting a product of 1,393&#xa0;bp. All lines produced amplicons of the expected sizes (<xref ref-type="fig" rid="F7">Figure 7F</xref>), and all sequences showed hybrid <italic>attL</italic> and <italic>attR</italic> sites (<xref ref-type="sec" rid="s12">Supplementary Table S13</xref>). The PhiC31 integrase plasmid itself carries an <italic>attB</italic> site, a relic of its construction history. This may have lead to some integration of the PhiC31 plasmid itself. The PhiC31 integrase plasmid has no fluorescence marker so such insertions would not have been recognised; since integration into <italic>attP</italic> is exclusive (first insertion alters the site) double insertions were not expected or identified. To the extent that some wild-type chromosomes were modified in this way and therefore not accessible to integration by the marked plasmid, the insertion rates of <xref ref-type="table" rid="T1">Table 1</xref> may be slight underestimates.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>4 Discussion</title>
<p>Both Cre and PhiC31 catalyse recombination between specific sequences, <italic>lox</italic> and <italic>att</italic> sites, respectively. These sequences are long enough to be absent from most genomes, so that recombination can be specifically directed to artificially integrated sequences. Furthermore, these sequences are stable in the absence of the relevant enzyme, and the enzyme is essentially inert in the absence of the target sequences. This allows considerable scope for controlling the recombination reaction by combining the two components only under specific conditions. Examples might include crossing two strains, injecting a source of enzyme, e.g., a plasmid encoding the enzyme, etc.</p>
<p>Site-specific integration is desirable over other methods as it can use target sites that have previously been characterised for their pattern and levels of expression, avoiding having to maintain and characterise several mosquito lines with different insertions, or even having to resolve multiple insertions. Targeted integration may now be achieved using CRISPR/Cas-mediated homologous recombination in many cases. This method requires, however, knowledge of the target genome to be able to generate suitable guides (followed by analysis of the efficiency/specificity of those guides) and homology arms, and identify desirable target sites avoiding repetitive sequences and pseudogenes. It also depends on homology-directed repair (HDR) to happen preferably over non-homologous end joining (NHEJ) after the double-strand break is made by the Cas enzyme. Although this may be achieved by silencing elements of the NHEJ pathway (see <xref ref-type="bibr" rid="B10">Basu et al., 2015</xref> for example, in <italic>Ae. aegypti</italic>), this adds an extra layer of complexity to the process.</p>
<p>Considering all the potential limitations described above for CRISPR/Cas-mediated integration, PhiC31 remains an efficient alternative. Unlike for CRISPR/Cas, one <italic>att</italic> site needs to be integrated by other means before the PhiC31 method can be used for integration into the germline. This may be efficiently achieved by establishing &#x201c;docking lines&#x201d; where <italic>attP</italic> is inserted in a relatively well-characterised site. This characterisation of the site can be done by sequencing (if a reference genome is available) or by analysing the fitness of the transgenic individual (if the genome is unknown). Besides, although we only inserted a plasmid of approx. 6&#xa0;kb, it is known that this recombinase can integrate the over 40&#xa0;kb <italic>Streptomyces</italic> phage PhiC31 genome (<xref ref-type="bibr" rid="B11">Chater et al., 1981</xref>), and it is thought that it could have no upper size limit (<xref ref-type="bibr" rid="B29">Olivares and Calos, 2004</xref>), broadening the spectrum of possible transformations.</p>
<p>Using a plasmid-encoded source of PhiC31, we achieved efficient integration into <italic>attP</italic> sites in each of the three chromosomes of <italic>Ae. aegypti,</italic> with efficiency levels between 10% and 22%. Previous experiments in <italic>Ae. aegypti</italic> by <xref ref-type="bibr" rid="B28">Nimmo et al<italic>.</italic> (2006)</xref> using PhiC31 mRNA, had an average efficiency of 23%. It is worth noting the following differences between our and their study: i) we injected 318&#x2013;334 eggs while they injected 689&#x2013;1,195; this affects the number of plasmids that can be injected per session, or the number of people/equipment necessary to perform the task, as well as making more difficult the handling of the G<sub>0</sub> depending of the survival rate, ii) we obtained in total between 10 and 88 positive G<sub>1</sub> in both male and female G<sub>0</sub> pools, while they obtained between 1 and 11 positive G<sub>1</sub> males only in the male G<sub>0</sub> pools (no information is provided regarding G<sub>1</sub> females); although theoretically one single transgenic G<sub>1</sub> individuals is required to start a line, as initial survival of transgenics can be poor, the generation of more than one transgenic G<sub>1</sub> is desired, iii) we used three mosquito lines with single <italic>attP</italic> sites in each chromosome of <italic>Ae. aegypti</italic>, while they used two lines with single insertions, one with two insertions, and one with four insertions. Even if the efficiencies are similar, it is clear that the use of a plasmid for the expression of the PhiC31 integrase simplifies the microinjection procedure.</p>
<p>PhiC31 integrates the entire plasmid but, as we demonstrated, undesired sequences can be flanked by <italic>lox</italic> sites to allow efficient subsequent removal. In one special case of this, the docking site might incorporate both <italic>attP</italic> and <italic>lox</italic>, allowing cassette exchange in two steps (PhiC31 recombinase and Cre provided sequentially) or one step (PhiC31 recombinase and Cre provided together) (<xref ref-type="bibr" rid="B16">Haghighat-Khah et al., 2015</xref>).</p>
<p>Site-specific recombination has many potential uses, and has been used extensively in insects genetics (e.g., <xref ref-type="bibr" rid="B34">Venken et al., 2016</xref>; <xref ref-type="bibr" rid="B1">Ahmed and Wimmer, 2022</xref>). Potentially deleterious transgenes may be inactivated by inserting a redundant fragment of DNA that interrupts the gene, then activated by recombination-induced removal of the redundant DNA post-integration. Recombination sites may be inserted within or between genes, allowing specific chromosome deletions or rearrangements to be generated as desired.</p>
<p>We also demonstrated that more complex rearrangements can be induced post-integration. Using overlapping <italic>lox</italic>P and <italic>lox</italic>N pairs, we were able to recover both <italic>lox</italic>P and <italic>lox</italic>N recombinants. These are mutually exclusive pathways, given that recombination between <italic>lox</italic>P removes one of the <italic>lox</italic>N sites, and <italic>lox</italic>N recombination similarly removes the <italic>lox</italic>P site.</p>
<p>Post-integration Cre-<italic>lox</italic> manipulations are preferably managed by crossing in a source of Cre. This allows the use of very low numbers of insects, such as may be available in the first generations after constructing a new transgenic line, whereas injection experiments need substantial numbers of eggs, as well as being considerably more time-consuming than simple crosses. It also removes the effect of injection as a confounding factor when comparing pre- and post-recombination phenotypes. We demonstrated that Cre-mediated <italic>lox</italic>P recombination can be efficiently achieved in the germline using an integrated Cre source (Shu-Cre). With recombination rates at the observed level&#x2014;approx. 15%&#x2013;17% with two types of <italic>lox</italic> sites present and 32%&#x2013;37% with <italic>lox</italic>N only, though this may vary somewhat by insertion&#x2014;the desired recombinant can likely be recovered from the progeny of only one or a few initial Cre-<italic>lox</italic> insects.</p>
<p>This set of experiments expands the toolbox for synthetic biology in <italic>Ae. aegypti.</italic> It is highly likely that these methods can be transferred to other mosquito species, as many species of public health importance are now reared and manipulated in the laboratory. In turn, this expands the options both for fundamental studies to better understand the insects, and for applied approaches aiming to develop new methods of controlling mosquito populations and the pathogens that they transmit.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement </title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="sec" rid="s12">Supplementary Material</xref>.</p>
</sec>
<sec id="s6">
<title>Ethics statement </title>
<p>All mosquito procedures were reviewed and approved by the Biological Agents and Genetic Modification Safety Committee (BAGMSC) at The Pirbright Institute.</p>
</sec>
<sec id="s7">
<title>Author contributions </title>
<p>LC: Conceptualization, Investigation, Methodology, Writing&#x2013;original draft. RW: Investigation, Writing&#x2013;review and editing. PT: Investigation, Methodology, Writing&#x2013;review and editing. VD: Investigation, Writing&#x2013;review and editing. EK: Investigation, Writing&#x2013;review and editing. PC: Investigation, Writing&#x2013;review and editing. WL: Investigation, Writing&#x2013;review and editing. SR: Investigation, Writing&#x2013;review and editing. MN: Investigation, Writing&#x2013;review and editing. AU: Investigation, Writing&#x2013;review and editing. LW: Investigation, Writing&#x2013;review and editing. MA: Resources, Writing&#x2013;review and editing. SB: Methodology, Writing&#x2013;review and editing. PL: Conceptualization, Methodology, Writing&#x2013;review and editing. LA: Conceptualization, Writing&#x2013;review and editing.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This research was funded in whole, or in part, by the Wellcome Trust (110117/Z/15/Z and 200171/Z/15/Z). This research was funded in part by the Defense Advanced Research Projects Agency (DARPA) Safe Genes program (N66001-17-2-4054) and PREventing EMerging Pathogenic Threats (PREEMPT) program (HR001118S0017). This work was also supported by strategic funding from the UK Biotechnology and Biological Sciences Research Council (BBSRC) to The Pirbright Institute (BBS/E/I/00007033, BBS/E/I/00007038, and BBS/E/I/00007039).</p>
</sec>
<ack>
<p>The authors thank Victoria Sy for her assistance in the Insectary during the development of the attP-AeCPA-tTA transgenic line.</p>
</ack>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest </title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11">
<title>Author disclaimer</title>
<p>The views, opinions and/or findings expressed are those of the author and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. Government. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.</p>
</sec>
<sec id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fbioe.2023.1254863/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fbioe.2023.1254863/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Ahmed</surname>
<given-names>H. M. M.</given-names>
</name>
<name>
<surname>Wimmer</surname>
<given-names>E. A.</given-names>
</name>
</person-group> (<year>2022</year>). &#x201c;<article-title>Site-specific recombination for gene locus-directed transgene integration and modification</article-title>,&#x201d; in <source>Transgenic insects: Techniques and applications</source> (<publisher-name>CABI</publisher-name>), <fpage>100</fpage>&#x2013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1079/9781800621176.0005</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albert</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Dale</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ow</surname>
<given-names>D. W.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome</article-title>. <source>Plant J.</source> <volume>7</volume>, <fpage>649</fpage>&#x2013;<lpage>659</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-313X.1995.7040649.x</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alphey</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Genetic control of mosquitoes</article-title>. <source>Annu. Rev. Entomol.</source> <volume>59</volume>, <fpage>205</fpage>&#x2013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-ento-011613-162002</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>M. A. E.</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ang</surname>
<given-names>J. X. D.</given-names>
</name>
<name>
<surname>Shackleford</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Nevard</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Verkuijl</surname>
<given-names>S. A. N.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Closing the gap to effective gene drive in <italic>Aedes aegypti</italic> by exploiting germline regulatory elements</article-title>. <source>Nat. Commun.</source> <volume>14</volume>, <fpage>338</fpage>&#x2013;<lpage>339</lpage>. <pub-id pub-id-type="doi">10.1038/s41467-023-36029-7</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>M. A. E.</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Edgington</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Ang</surname>
<given-names>J. X. D.</given-names>
</name>
<name>
<surname>Purusothaman</surname>
<given-names>D.-K.</given-names>
</name>
<name>
<surname>Shackleford</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>A multiplexed, confinable CRISPR/Cas9 gene drive propagates in caged</article-title>. <source>bioRxiv</source>. <pub-id pub-id-type="doi">10.1101/2022.08.12.503466</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>M. A. E.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Myles</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Adelman</surname>
<given-names>Z. N.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Validation of novel promoter sequences derived from two endogenous ubiquitin genes in transgenic <italic>Aedes aegypti</italic>
</article-title>. <source>Insect Mol. Biol.</source> <volume>19</volume>, <fpage>441</fpage>&#x2013;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2583.2010.01005.x</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Araki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Araki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamamura</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Targeted integration of DNA using mutant lox sites in embryonic stem cells</article-title>. <source>Nucleic Acids Res.</source> <volume>25</volume>, <fpage>868</fpage>&#x2013;<lpage>872</lpage>. <pub-id pub-id-type="doi">10.1093/nar/25.4.868</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Austin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ziese</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sternberg</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>A novel role for site-specific recombination in maintenance of bacterial replicons</article-title>. <source>Cell</source> <volume>25</volume>, <fpage>729</fpage>&#x2013;<lpage>736</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(81)90180-X</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartholomeeusen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Utt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Coppens</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rausalu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vereecken</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ari&#xeb;n</surname>
<given-names>K. K.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>A chikungunya virus trans -replicase system reveals the importance of delayed nonstructural polyprotein processing for efficient replication complex formation in mosquito cells</article-title>. <source>J. Virol.</source> <volume>92</volume>, <fpage>001522</fpage>&#x2013;<lpage>e218</lpage>. <pub-id pub-id-type="doi">10.1128/jvi.00152-18</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Aryan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Overcash</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Samuel</surname>
<given-names>G. H.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>M. A. E.</given-names>
</name>
<name>
<surname>Dahlem</surname>
<given-names>T. J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Silencing of end-joining repair for efficient site-specific gene insertion after TALEN/CRISPR mutagenesis in <italic>Aedes aegypti</italic>
</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>112</volume>, <fpage>4038</fpage>&#x2013;<lpage>4043</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1502370112</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chater</surname>
<given-names>K. F.</given-names>
</name>
<name>
<surname>Bruton</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Springer</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Suarez</surname>
<given-names>J. E.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>Dispensable sequences and packaging constraints of DNA from the Streptomyces temperate phage phi C31</article-title>. <source>Gene</source> <volume>15</volume>, <fpage>249</fpage>&#x2013;<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1016/0378-1119(81)90134-7</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coates</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Jasinskiene</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Miyashiro</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>James</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Mariner transposition and transformation of the yellow fever mosquito, <italic>Aedes aegypti</italic>
</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>95</volume>, <fpage>3748</fpage>&#x2013;<lpage>3751</lpage>. <pub-id pub-id-type="doi">10.1073/PNAS.95.7.3748</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franz</surname>
<given-names>A. W. E.</given-names>
</name>
<name>
<surname>Jasinskiene</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sanchez-Vargas</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Isaacs</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Khoo</surname>
<given-names>C. C. H.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Comparison of transgene expression in <italic>Aedes aegypti</italic> generated by mariner Mos1 transposition and &#x3a6;C31 site-directed recombination</article-title>. <source>Insect Mol. Biol.</source> <volume>20</volume>, <fpage>587</fpage>&#x2013;<lpage>598</lpage>. <pub-id pub-id-type="doi">10.1111/J.1365-2583.2011.01089.X</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gossen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bujard</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Tight control of gene expression in mammalian cells by tetracycline-responsive promoters</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>89</volume>, <fpage>5547</fpage>&#x2013;<lpage>5551</lpage>. <pub-id pub-id-type="doi">10.1073/PNAS.89.12.5547</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>H&#xe4;cker</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Harrell</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Eichner</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pilitt</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>O&#x2019;Brochta</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Handler</surname>
<given-names>A. M.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Cre/lox-Recombinase-Mediated cassette exchange for reversible site-specific genomic targeting of the disease vector, <italic>Aedes aegypti</italic>
</article-title>. <source>Sci. Rep.</source> <volume>7</volume>, <fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1038/srep43883</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haghighat-Khah</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Scaife</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Martins</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>St. John</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Matzen</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Site-specific cassette exchange systems in the <italic>Aedes aegypti</italic> mosquito and the plutella xylostella moth</article-title>. <source>PLoS One</source> <volume>10</volume>, <fpage>e0121097</fpage>. <pub-id pub-id-type="doi">10.1371/JOURNAL.PONE.0121097</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoess</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Wierzbicki</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Abremski</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>The role of the<italic>loxP</italic>spacer region in PI site-specific recombination</article-title>. <source>Nucleic Acids Res.</source> <volume>14</volume>, <fpage>2287</fpage>&#x2013;<lpage>2300</lpage>. <pub-id pub-id-type="doi">10.1093/nar/14.5.2287</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoess</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Ziese</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sternberg</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>1982</year>). <article-title>P1 site-specific recombination: nucleotide sequence of the recombining sites</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>79</volume>, <fpage>3398</fpage>&#x2013;<lpage>3402</lpage>. <pub-id pub-id-type="doi">10.1073/PNAS.79.11.3398</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jasinskiene</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Coates</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Ashikyan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>James</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>High efficiency, site-specific excision of a marker gene by the phage P1 cre-loxP system in the yellow fever mosquito, <italic>Aedes aegypti</italic>
</article-title>. <source>Nucleic Acids Res.</source> <volume>31</volume>, <fpage>147e</fpage>&#x2013;<lpage>147e</lpage>. <pub-id pub-id-type="doi">10.1093/NAR/GNG148</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Kassambara</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>rstatix: pipe-Friendly Framework for Basic Statistical Tests. R package version 0.7.2</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=rstatix">https://cran.r-project.org/package&#x3d;rstatix</ext-link>
</comment>.</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khoo</surname>
<given-names>C. C. H.</given-names>
</name>
<name>
<surname>Doty</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Heersink</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>K. E.</given-names>
</name>
<name>
<surname>Franz</surname>
<given-names>A. W. E.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Transgene-mediated suppression of the RNA interference pathway in <italic>Aedes aegypti</italic> interferes with gene silencing and enhances Sindbis virus and dengue virus type 2 replication</article-title>. <source>Insect Mol. Biol.</source> <volume>22</volume>, <fpage>104</fpage>&#x2013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1111/IMB.12008</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Langer</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Ghafoori</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Byrd</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Leinwand</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>A genetic screen identifies novel non-compatible loxP sites</article-title>. <source>Nucleic Acids Res.</source> <volume>30</volume>, <fpage>3067</fpage>&#x2013;<lpage>3077</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkf421</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination</article-title>. <source>Gene</source> <volume>216</volume>, <fpage>55</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-1119(98)00325-4</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Y. G.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>High-efficiency thermal asymmetric interlaced PCR for amplification of unknown flanking sequences</article-title>. <source>Biotechniques</source> <volume>43</volume>, <fpage>649</fpage>&#x2013;<lpage>656</lpage>. <pub-id pub-id-type="doi">10.2144/000112601</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Livet</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Weissman</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Draft</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bennis</surname>
<given-names>R. A.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system</article-title>. <source>Nature</source> <volume>450</volume>, <fpage>56</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/nature06293</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martins</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Naish</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Morrison</surname>
<given-names>N. I.</given-names>
</name>
<name>
<surname>Scaife</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Germline transformation of the diamondback moth, Plutella xylostella L., using the piggyBac transposable element</article-title>. <source>Insect Mol. Biol.</source> <volume>21</volume>, <fpage>414</fpage>&#x2013;<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2583.2012.01146.x</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagy</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Cre recombinase: the universal reagent for genome tailoring</article-title>. <source>Genesis</source> <volume>26</volume>, <fpage>99</fpage>&#x2013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1526-968X(200002)26:2&#x3c;99::AID-GENE1&#x3e;3.0.CO;2-B</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nimmo</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Alphey</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Meredith</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Eggleston</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>High efficiency site-specific genetic engineering of the mosquito genome</article-title>. <source>Insect Mol. Biol.</source> <volume>15</volume>, <fpage>129</fpage>&#x2013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1111/J.1365-2583.2006.00615.X</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olivares</surname>
<given-names>E. C.</given-names>
</name>
<name>
<surname>Calos</surname>
<given-names>M. P.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Phage &#x3c6;C31 integrase-mediated site-specific integration for gene therapy</article-title>. <source>Gene Ther. Regul.</source> <volume>2</volume>, <fpage>103</fpage>&#x2013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1163/156855803322664600</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="web">
<collab>R Core Team</collab> (<year>2022</year>). <article-title>R: A language and environment for statistical computing</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.R-project.org">www.R-project.org</ext-link>
</comment>.</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sauer</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Functional expression of the cre-lox site-specific recombination system in the yeast <italic>Saccharomyces cerevisiae</italic>
</article-title>. <source>Mol. Cell. Biol.</source> <volume>7</volume>, <fpage>2087</fpage>&#x2013;<lpage>2096</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.7.6.2087-2096.1987</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thorpe</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>M. C. M.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>
<italic>In vitro</italic> site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>95</volume>, <fpage>5505</fpage>&#x2013;<lpage>5510</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.10.5505</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Venables</surname>
<given-names>W. N.</given-names>
</name>
<name>
<surname>Ripley</surname>
<given-names>B. D.</given-names>
</name>
</person-group> (<year>2002</year>). in <source>Modern applied statistics with S</source>. Editors <person-group person-group-type="editor">
<name>
<surname>Chambers</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Eddy</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>H&#xe4;rdle</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sheather</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tierney</surname>
<given-names>L.</given-names>
</name>
</person-group> <edition>4th ed.</edition> (<publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name>). <pub-id pub-id-type="doi">10.1007/978-0-387-21706-2</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venken</surname>
<given-names>K. J. T.</given-names>
</name>
<name>
<surname>Sarrion-Perdigones</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vandeventer</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Abel</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Christiansen</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>K. L.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Genome engineering: drosophila melanogaster and beyond</article-title>. <source>Wiley Interdiscip. Rev. Dev. Biol.</source> <volume>5</volume>, <fpage>233</fpage>&#x2013;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1002/wdev.214</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Wickham</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fran&#xe7;ois</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Henry</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vaughan</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Dplyr: A grammar of data manipulation. R package version 1.1.0</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://CRAN.R-project.org/package=dplyr">CRAN.R-project.org/package&#x3d;dplyr</ext-link>
</comment>.</citation>
</ref>
<ref id="B36">
<citation citation-type="web">
<collab>World Health Organisation</collab> (<year>2014</year>). <article-title>A global brief on vector-borne diseases</article-title>. <comment>Available at: <ext-link ext-link-type="uri" xlink:href="http://www.who.int">www.who.int</ext-link> (Accessed August 7, 2020)</comment>.</citation>
</ref>
</ref-list>
</back>
</article>